PETINIMID 250mg capsules medication leaflet

N03AD01 ethosuximide • Nervous system | Antiepileptics | Succinimide derivatives

Ethosuximide is an anticonvulsant medication mainly used for the treatment of absence seizures in children and adults. It works by reducing abnormal electrical activity in the brain, helping to prevent absence seizures.

Ethosuximide is administered orally as capsules or syrup, according to the neurologist's instructions. The dose is adjusted individually, depending on the patient's response to treatment and any side effects.

Side effects may include nausea, vomiting, headaches, drowsiness, or, rarely, allergic reactions and liver or blood disorders. Medical monitoring is necessary throughout the treatment.

Ethosuximide is an effective option for controlling absence seizures, but its use requires careful medical supervision to manage possible side effects and ensure treatment effectiveness.

General data about PETINIMID 250mg

Substance: ethosuximide

Date of last drug list: 01-05-2026

Commercial code: W69257001

Concentration: 250mg

Pharmaceutical form: capsules

Quantity: 100

Product type: generic

Price: 210.49 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: G.L. PHARMA GMBH - AUSTRIA

Holder: FARMEXIM S.A. - ROMANIA

Number: 762/2022/01

Shelf life: 4 years

Pharmaceutical forms available for ethosuximide

Concentrations available for ethosuximide

250mg, 50mg/ml